The benefit of EAHE in reducing cognitive decline may be associated with improved blood biomarkers such as calcium, albumin, Hb, Hcy, SOD, BDNF, APOE4, and α-ACT, as well as reduced structural deterioration in the ARC and PHC regions of patients with mild AD. Here, BDNF is linked to Alzheimer disease.